ResearcherGerman Cancer Research CenterActive in the last 2 years
Orkhan Isayev
Matched on ORCID iD 0000-0002-9673-7458; OpenAlex author ID A5000590440. Sources: OpenAlex.
Their work
- Papers
- 5
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 19
2014: 2 papers · 2015: none · 2016: none · 2017: 1 paper · 2018: none · 2019: none · 2020: none · 2021: none · 2022: 1 paper · 2023: none · 2024: 1 paper
Papers 5
- Investigation of an anticancer activity of combination of interferon-alpha and gemcitabine on pancreatic cancer cells. Co-author DOI 10.4103/jcrt.jcrt_138_23↗
- Pivotal antitumor role of the immune checkpoint molecule B7-H1 in pancreatic cancer. Co-author DOI 10.1080/2162402x.2022.2043037↗
- MiRNAs are Unlikely to be Involved in Retinoid Receptor Gene Regulation in Pancreatic Cancer Cells. Co-author DOI 10.1159/000485276↗
- Sulforaphane counteracts aggressiveness of pancreatic cancer driven by dysregulated Cx43-mediated gap junctional intercellular communication. Co-author DOI 10.18632/oncotarget.1764↗
- Inhibition of glucose turnover by 3-bromopyruvate counteracts pancreatic cancer stem cell features and sensitizes cells to gemcitabine. Co-author DOI 10.18632/oncotarget.2120↗
Closest collaborators
The 19 strongest of 19 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Eldar Kochari Gasimov · 1 shared paper, 2024 · strength 0.28
- Alexandr V. Bazhin · 3 shared papers, 2014–2022 · strength 0.27
- Paper Pivotal antitumor role of the immune checkpoint molecule B7-H1 in pancreatic cancer. DOI 10.1080/2162402x.2022.2043037↗
- Paper MiRNAs are Unlikely to be Involved in Retinoid Receptor Gene Regulation in Pancreatic Cancer Cells. DOI 10.1159/000485276↗
- Paper Inhibition of glucose turnover by 3-bromopyruvate counteracts pancreatic cancer stem cell features and sensitizes cells… DOI 10.18632/oncotarget.2120↗
- Svetlana Karakhanova · 1 shared paper, 2022 · strength 0.16
- Jens Thomas Siveke · 1 shared paper, 2022 · strength 0.16
- Tim Bleul · 1 shared paper, 2017 · strength 0.08
- Jens Martin Werner · 1 shared paper, 2017 · strength 0.08
- Shuai Yin · 1 shared paper, 2017 · strength 0.08
- Clifford C. Nwaeburu · 2 shared papers, 2014 · strength 0.07
- Paper Inhibition of glucose turnover by 3-bromopyruvate counteracts pancreatic cancer stem cell features and sensitizes cells… DOI 10.18632/oncotarget.2120↗
- Paper Sulforaphane counteracts aggressiveness of pancreatic cancer driven by dysregulated Cx43-mediated gap junctional interc… DOI 10.18632/oncotarget.1764↗
- Yiyao Zhang · 2 shared papers, 2014 · strength 0.07
- Paper Inhibition of glucose turnover by 3-bromopyruvate counteracts pancreatic cancer stem cell features and sensitizes cells… DOI 10.18632/oncotarget.2120↗
- Paper Sulforaphane counteracts aggressiveness of pancreatic cancer driven by dysregulated Cx43-mediated gap junctional interc… DOI 10.18632/oncotarget.1764↗
- Ingrid Herr · 2 shared papers, 2014 · strength 0.07
- Paper Inhibition of glucose turnover by 3-bromopyruvate counteracts pancreatic cancer stem cell features and sensitizes cells… DOI 10.18632/oncotarget.2120↗
- Paper Sulforaphane counteracts aggressiveness of pancreatic cancer driven by dysregulated Cx43-mediated gap junctional interc… DOI 10.18632/oncotarget.1764↗
- Nathalie Bauer · 1 shared paper, 2014 · strength 0.03
- Pei Fan · 1 shared paper, 2014 · strength 0.03
- Felix Rückert · 1 shared paper, 2014 · strength 0.03
- Tobias Förster · 1 shared paper, 2014 · strength 0.03
- Michael Schaefer · 1 shared paper, 2014 · strength 0.03
- Nathalia A. Giese · 1 shared paper, 2014 · strength 0.03
- Peter Schemmer · 1 shared paper, 2014 · strength 0.03
- Li Liu · 1 shared paper, 2014 · strength 0.03
- Jens Werner · 1 shared paper, 2014 · strength 0.03
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.